Form UPLOAD - SEC-generated letter:
SEC Accession No. 0000000000-15-056788
Filing Date
2015-12-07
Accepted
2015-12-07 16:32:31
Documents
1

Document Format Files

Seq Description Document Type Size
1 filename1.pdf LETTER 109351
  Complete submission text file 0000000000-15-056788.txt   151343
Mailing Address 1030 MASSACHUSETTS AVE. CAMBRIDGE MA 02138
Business Address 1030 MASSACHUSETTS AVE. CAMBRIDGE MA 02138 857-259-3840
Jounce Therapeutics, Inc. (Filed for) CIK: 0001640455 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: UPLOAD
SIC: 2836 Biological Products, (No Diagnostic Substances)